Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
7.20
+0.38 (5.50%)
At close: May 12, 2025, 4:00 PM
7.34
+0.14 (2.02%)
After-hours: May 12, 2025, 7:09 PM EDT
Treace Medical Concepts Market Cap
Treace Medical Concepts has a market cap or net worth of $452.60 million as of May 12, 2025. Its market cap has decreased by -31.51% in one year.
Market Cap
452.60M
Enterprise Value
445.88M
1-Year Change
-31.51%
Ranking
Category
Stock Price
$7.20
Market Cap Chart
Since the IPO on April 23, 2021, Treace Medical Concepts's market cap has decreased from $889.74M to $452.60M, a decrease of -49.13%. That is a compound annual growth rate of -15.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 429.01M | -7.44% |
| Dec 31, 2024 | 463.49M | -41.06% |
| Dec 29, 2023 | 786.37M | -38.37% |
| Dec 30, 2022 | 1.28B | 28.74% |
| Dec 31, 2021 | 991.14M | 11.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |